NGM Biopharmaceuticals, Inc.
NASDAQ:NGM
1.54 (USD) • At close April 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 58.815 | 73.456 | 151.795 | 147.017 | 245.598 | 56.923 | 25.593 | 45.463 |
| Short Term Investments
| 88.369 | 198.036 | 214.458 | 148.139 | 98.913 | 149.71 | 148.092 | 184.729 |
| Cash and Short Term Investments
| 147.184 | 271.492 | 366.253 | 295.156 | 344.511 | 206.633 | 173.685 | 230.192 |
| Net Receivables
| 0.058 | 7.58 | 4.945 | 6.433 | 5.206 | 3.669 | 0 | 2.769 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 9.202 | 9.787 | 8.082 | 6.837 | 5.531 | 4.255 | 1.848 | 1.72 |
| Total Current Assets
| 156.444 | 288.859 | 379.28 | 308.426 | 355.248 | 214.557 | 175.533 | 234.681 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 7.033 | 10.592 | 14.116 | 14.526 | 19.475 | 23.893 | 24.873 | 27.194 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 2.455 | 3.954 | 1.499 | 1.499 | 1.874 | 0 | 45.15 | 12.709 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.936 | 3.997 | 7.492 | 4.592 | 3.806 | 7.635 | 3.385 | 2.41 |
| Total Non-Current Assets
| 12.424 | 18.543 | 23.107 | 20.617 | 25.155 | 31.528 | 73.408 | 42.313 |
| Total Assets
| 168.868 | 307.402 | 402.387 | 329.043 | 380.403 | 246.085 | 248.941 | 276.994 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 2.982 | 8.453 | 5.246 | 9.663 | 9.026 | 5.775 | 1.892 | 8.424 |
| Short Term Debt
| 0 | 5.385 | 5.077 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.366 | 17.774 | 0 | 4.872 | 19.025 | 21.358 | 19.079 |
| Other Current Liabilities
| 17.099 | 33.638 | 33.258 | 32.92 | 25.82 | 16.686 | 13.643 | 10.19 |
| Total Current Liabilities
| 20.081 | 47.842 | 61.355 | 42.583 | 39.718 | 41.486 | 36.893 | 37.693 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 0 | 5.385 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 3.942 | 22.742 | 41.542 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.149 | 0 | 0 | 6.417 | 9.966 | 13.78 | 310.284 | 312.821 |
| Total Non-Current Liabilities
| 0.149 | 14.204 | 5.385 | 6.417 | 9.966 | 17.722 | 333.026 | 354.363 |
| Total Liabilities
| 20.23 | 47.842 | 66.74 | 49 | 49.684 | 59.208 | 369.919 | 392.056 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 380.403 | 0 | 0 | 0 |
| Common Stock
| 0.083 | 0.082 | 0.078 | 0.071 | 0.067 | 0.054 | 0.012 | 0.011 |
| Retained Earnings
| -724.008 | -581.633 | -418.966 | -298.631 | -196.144 | -147.193 | -146.7 | -132.541 |
| Accumulated Other Comprehensive Income/Loss
| 0.018 | -0.302 | -0.129 | 0.004 | 0.025 | -0.267 | -0.431 | -0.102 |
| Other Total Stockholders Equity
| 872.545 | 841.413 | 754.664 | 578.599 | 146.368 | 334.283 | 26.141 | 17.57 |
| Total Shareholders Equity
| 148.638 | 259.56 | 335.647 | 280.043 | 330.719 | 186.877 | -120.978 | -115.062 |
| Total Equity
| 148.638 | 259.56 | 335.647 | 280.043 | 330.719 | 186.877 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 168.868 | 307.402 | 402.387 | 329.043 | 380.403 | 246.085 | 248.941 | 276.994 |